| Nature of the Projects & Investigators |
Name of the funding Agency |
|
Chronic toxicity studies of “Punarnavadi mandura“ – Dr. B. Ravishankra (PI) |
AYUSH, New Delhi |
|
Chronic toxicity studies of Kashisha Bhasma – Dr. B. Ravishankra (PI) |
AYUSH, New Delhi |
|
Acute and chronic toxicity study on coded drug “W” – Drug from JAMA controversy CCRAS project. – Dr. B. Ravishankra (PI) |
CCRAS, New Delhi |
|
Acute and chronic toxicity study on coded drug “U” – Drug from JAMA controversy CCRAS project. – Dr. B. Ravishankra (PI) |
CCRAS, New Delhi |
|
Acute and chronic toxicity study on coded drug “T” – Drug from JAMA controversy CCRAS project. – Dr. B. Ravishankra (PI) |
CCRAS, New Delhi |
|
Sub-acute and chronic toxicity study on coded drug “Un” Rasakalpa/Bhasmas – Dr. B. Ravishankra (PI) |
CCRAS, New Delhi |
|
Sub-acute and Chronic Toxicity Study of Coded Drug “Xn – Dr. B. Ravishankra (PI) |
CCRAS, M/o AYUSH, Govt. of India, New Delhi |
|
Sub-acute and Chronic Toxicity Study of Coded Drug “Tj” – Dr. B. Ravishankra (PI) |
CCRAS, M/o AYUSH, Govt. of India, New Delhi |
|
Standardization and Clinical Evaluation of Keshanjan, an Ayurvedic Formulation in Shushkakship aka (Dry Eye Syndrome) – Dr. K.S. Dhiman (PI) |
CCRAS, M/o AYUSH, Govt. of India, New Delhi |
|
Identification of Genomic Correlates of Prakriti in Healthy Individuals in West Indian Population of Gujarat – Dr. A.B. Thakar (PI), Dr. Mandip Goyal (Co-PI) |
CSIR Ayurgenomics Unit, Institute of Genomics and Integrative Biology, New Delhi |
|
Development of standardization of harvesting and good collection practice of two latex bearing plants i.e. Arka (Calotropis gigantea L.R.Br. ex Ait. & Calotropis procera Ait R.Br.) and Sunthi (Euphorbia nerifolia Linn.) – Dr. R.N. Acharya (PI), Dr. V.J. Shukla (Co-I), Dr. Anagha Ranade (Co-I) |
National Medicinal Plant Board, M/o AYUSH, Govt. of India, New Delhi |
|
Experimental evaluation of cardioprotective activity of Ayurvedic herbal formulation- Arjunadi Yoga- Dr. M.B. Nariya (PI), Dr. K. Nishtenshwar (Co-I), Dr. Sushma Bhuvad (Co-I) |
National Medicinal Plant Board, M/o AYUSH, Govt. of India, New Delhi |
|
Development and validation of Prikriti assessment questioner /scale- Dr. A.S. Baghel (PI-1), Dr. Shalini Mishra (PI-2) |
CCRAS, M/o AYUSH, Govt. of India, New Delhi |
| Developing SOP of Rasa Manikya and Tribhuvan Kirti Rasa- Prof. B.J. Patgiri (PI) | CCRAS, M/o AYUSH, Govt. of India, New Delhi |
| Nature of the Projects | Investigators |
| Experimental Evaluation of Anti-cataract effect of Vasanjan – an indigenous preparation | Dr. Manjusha R (PI) |
| Pharmacognostical Evaluation of certain Anukta Dravyas (extra pharmacoepial medicinal plants) | Dr. RN Acharya (PI), Dr. Harisha CR (Co-I), Dr. VJ Shukla (Co-I) |
| Validation of HPTLC Methods for Identification of Botanicals in GMP Environment | Dr. VJ Shukla (PI), Prof. RN Acharya (Co-I) |
| A clinical study on Ardhavabhedaka – Migraine and its Management with Laghu Sutashekhara Rasa and Brihat Dashamoola Taila Nasya | Dr. DB Vaghela (PI) |
| Systematic review of researches on Tamaka Shwasa (Bronchial Asthma) | Dr. Galib (PI) |
| Systematic review of researches on Vranaropana (Tissue Healing) properties of Ayurvedic drugs | Dr. T.S. Dudhmal (PI), Prof. S.K. Gupta (Co-I) |
| Systematic review of researches on female infertility (Vandhyatwa) at various Ayurvedic Research Institutes | Dr. L.P. Dei (PI) |
| Phyto-pharmacognostical and biological evaluation of five extra pharmacopoeial plants (Anukta Dravya) of Ayurveda | Prof. R.N. Acharya (PI), Dr. Harisha C.R. (Co-I), Dr. V.J. Shukla (Co-I) |
| Wound healing activity and safety profile of Securinega leucopyrus (Willd.) Muell. – An experimental study | Dr. T.S. Dudhmal (PI), Dr. M.B. Nariya (Co-I), Prof. S.K. Gupta (Co-I), Dr. Mahanta (Co-I) |
| Cell based in vitro and in vivo Pharmacological assessment of Limnophila rugosa (Roth.) Merr.-an Extra-Pharmacopoeial drug | Dr. M.B. Nariya (PI), Prof. R.N. Acharya (Co-I) |
| Digitalization of compilations of the drugs | Vd. B.R. Patel (PI), Prof. K Nishteswar (Co-I) |
| Pre-clinical and clinical studies on Naga Bhasma w.s.r. to Diabetes mellitus | Dr. B.J. Patgiri (PI), Prof. P.K. Prajapati (Co-I), Dr. M.B. Nariya (Co-I), Dr. V.J. Shukla (Co-I) |
| Nature of the Projects & Investigators |
Name of the funding Agency |
|
Experimental and clinical studies of Nagapheni (Opuntia elatior Mill.) an Anukta dravyas (extra- Pharmacoepial drug) w.s.r. to hematinic activity- Dr. R.N. Acharya (PI), Dr. M.B. Nariya (Co-I), Dr. Mandip Goyal (Co-I) |
M/o AYUSH, Govt. of India, New Delhi |
|
Validity and reliability testing of Ayurveda diagnostic methods Dr. Mandip Goyal (PI) |
CCRAS, M/o AYUSH, Govt. of India, New Delhi |
|
Elucidation of neroprotective mechanism of Haritaki – Prof. R.N. Acharya (Co-PI) |
DST, Science and Engineer Research Board, GoI, New Delhi |
|
Development and establishment of genetic markers for “Jivanti” and Ayurvedic medicinal materials – Prof. R.N. Acharya (Co-PI) |
DBT, Ministry of Science of Technology, GoI, New Delhi |
|
To review AYUSH interventionson COVID-19 in India- A living systematic review – Prof. Anup Thakar (PI)/ Dr. Mandip (I) Dr. Kalpesh (CO-PI), |
WHO SEARO |
| Nature of the Projects | Investigators |
| Safety assessment of Garbhapala Rasa – A retrospective study | Dr. Shilpa B. Donga (PI), Prof. L.P. Dei (Co-I) |
| Lexicon Edition of Charaka Samhita | Vd. Hiteshkumar Vyas (PI), Prof. M.K. Vyas (Co-I), Dr. AS Baghel (Co-I), Dr. Shubhangi Kamble (Co-I) |
| Assessment of genotoxic potential of Rasa Parpati and Swasakuthara Rasa | Dr. BJ Patgiri (PI), Dr. M.B. nariya (Co-PI) |
| Establishment of seed bank reservoir – A Research center | Dr. Harisha C.R. (PI), Dr.Bhupesh R Patel (Co-I) |
| Efficacy of Shallakyadi capsule in the prevention of post Chikungunya chronic inflammatory rheumatism- a prospective cohort study | Dr. Mandip Goyal (PI), Dr. Alkesh Pataliya (Co-PI), Dr. Gopinath Agnihotram (Co-PI) |
| To evaluate the efficacy of Paushtika Biscuit in the management of underweight children | Dr. V.K. Kori (PI), Prof. K.S. Patel (Co-PI) |
| Phyto-pharmacognostical evaluation of eight Anukta dravyas of Ayurveda | Dr. R.N. Acharya (PI), Dr. Harisha CR (Co-PI), Dr. V.J. Shukla (Co-PI) |
| Diabetic wound healing activity of two forms of Secureniga leucopyrus (Willd.) Muell.- A randomized controlled clinical multicenter trial | Dr. T.S. Dudhmal (PI), Dr. Ketan D. Mehta (Co-PI), Dr. VH Popaliya (Co-PI) |
| Encyclopedia of Astang Hriday and Ashtang Samgrah w.s.r. to their clinical terminology | Dr. Darshana Pandya (PI) |
| Preparation of Electronic database of PG and Ph.D. theses of IPGT&RA, GAU, Jamnagar | Dr. V.K. Kori (PI) |
| Pharmaceutical standardization of 100 puta Abhraka bhasma and Nagarjunabhra rasa with their in vivo Pharmacological evaluation on metabolic syndrome and cardioprotective activity – | Dr. Prashant Bedarkar (PI), Dr. M.B. Nariya (Co-PI), Prof. B.J. Patgiri (Co-PI) |
| Toxicity evaluation of Anandabhairava Rasa and its effects on gene expression in albino rats | Dr. M.B. Nariya (PI), Prof. B.J. Patgiri (Co-PI) |
| Association study between Sharir Prakriti and type 2 diabetes (Madhumeha) and its Ayurvedic management along with life style modification | Dr. Swati N Khandale (PI), Prof. A.S. Baghel (Co-PI) |
| A prospective non-randomized open label controlled interventional study on the effect of Guduchi Ghanavati as a prophylactic measure among population at high risk to SARS-CoV-2 exposure | Prof. Anup Thakar (PI), Dr. Kalpesh, Dr. Swapnil, Other team from State colleges |
| Clinical outcome of Ayurved treatment on COVID 19 patients: a retrospective cohort study | Prof. Anup Thakar (PI), Dr. Kalpesh, Dr. Falgun, Dr. Shital |
| Efficacy of Ayurveda intervention (AYUSH 64) as add-on therapy in COVID 19 patients – An open label randomized controlled trial | Prof. Anup Thakar (PI), Dr. Sagar, Dr. Mandip |
| Clinical outcome of Ayurveda medicines as add-on to conventional management in COVID-19 patients: A retrospective cohort study from Jamnagar, India | Prof. Anup Thakar (PI), Dr. N.N. Bhatt, Dr. Kalpesh Panara, Dr. Swati Khandale, Dr. Sagar Bhinde |